Acuerdo Marco del Suministro de MEDICAMENTOS ONCOLÓGICOS

Buyer

Consorci de Salut i d'Atenció Social de Catalunya

Winners

ACCORD HEALTHCARE, SLU, ADAMED LABORATORIOS, SLU, Amgen SA, ASPEN PHARMACARE ESPAÑA S.L., AUROVITAS SPAIN S.A., BIOCON BIOLOGICS SPAIN S.L., BRISTOL-MYERS SQUIBB SAU, EVER PHARMA TERAPEUTICS SPAIN, S.L., FRESENIUS KABI ESPAÑA, S.A., GLAXOSMITHKLINE, S.A., GP PHARM SAU, HIKMA ESPAÑA S.L.U, INCYTE BIOSCIENCES IBERIA, S.L., KERN PHARMA, LABORATORIO REIG JOFRE, S.A., LABORATORIOS CINFA S.A., LABORATORIOS NORMON, S.A., LAPHYSAN, MERCK, S.L., ORGANON SALUD, S.L., PFIZER SLU, PIERRE FABRE IBERICA S.A, REDDY PHARMA IBERIA,S.A, Sandoz Farmaceutica, TAKEDA FARMACEUTICA ESPAÑA, S.A., TEVA PHARMA, VIATRIS PHARMACEUTICALS, S.L., VIVANTA GENERICS S.R.O. SUCURSAL EN ESPAÑA

Contract value

no value published

Bids received

30

Published

8 Jun 2026

Awarded

8 Jun 2026

Contract start

8 Jun 2026

Contract end

9 Jun 2027estimated

Sector

Medical equipment and pharmaceuticals

Region

Barcelona

Source

Original notice on TED (393236-2026)

More awards from this buyer